Ines C. Moreno-Reynoso
Bern, BE 3010, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2026
Correction to "Exploring Simple Drug Scaffolds from the GDB Chemical Space Reveals a Chiral Bicyclic Azepane with Potent Neuropharmacology".
Journal: Journal of medicinal chemistry
Published: April 21, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2025
Exploring Simple Drug Scaffolds from the Generated Database Chemical Space Reveals a Chiral Bicyclic Azepane with Potent Neuropharmacology.
Journal: Journal of medicinal chemistry
Published: April 24, 2025
Assay of Endocannabinoid Uptake.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 24, 2022
Δ9-cis-Tetrahydrocannabinol: Natural Occurrence, Chirality, and Pharmacology.
Journal: Journal of natural products
Published: July 26, 2021
Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis.
Journal: ACS pharmacology & translational science
Published: December 15, 2020
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis.
Journal: European journal of medicinal chemistry
Published: June 01, 2020
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.
Journal: Oncogene
Published: September 25, 2019
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system.
Journal: Bioorganic chemistry
Published: August 27, 2019
Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.
Journal: Science advances
Published: June 13, 2018
The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors.
Journal: Frontiers in molecular neuroscience
Published: February 26, 2018
Last Updated: 09/26/2026